Business
BioSpectrum Asia
"Technology will play a significant role in reducing numbers of new cases and deaths"
‘Close the care gaps’ – a bold theme set for 2022-2024 World Cancer Day campaigns that fall on February 4 each year – intends to make a huge difference in delivering cancer care to the people.
5 min |
BioSpectrum Asia Feb 2023
BioSpectrum Asia
CANCER THERAPEUTICS GAINING GROUND IN APAC
Cancer, the leading cause of death in most parts of the world, is a veritable Achilles heel for the pharma industry.
10+ min |
BioSpectrum Asia Feb 2023
BioSpectrum Asia
Addressing Unmet Patient Needs in Antimicrobial Resistance (AMR): The Vital Role of Industry Partnerships
Interview- Mr Maurizio Luongo and Mr Zhao Hong
6 min |
BioSpectrum Asia Feb 2023
BioSpectrum Asia
Veradigm announces strategic investment in Holmusk from Singapore
US-based Veradigm has announced an investment in Holmusk, a global behavioural health real-world evidence and data analytics company in Singapore, as part of Holmusk’s $45 million series B financing round.
1 min |
BioSpectrum Asia Feb 2023
BioSpectrum Asia
DeepTek introduces new Al powered lumbar spine quantification automation tool
India-based health tech startup DeepTek has announced the global launch of DeepSpine - an artificial intelligence (AI) powered lumbar spine quantification and metrics tool designed to analyse MRI lumbar spine images.
1 min |
BioSpectrum Asia Feb 2023
BioSpectrum Asia
Moderna buys Japanese startup OriCiro for $85M
OriCiro Genomics, founded in December 2018, is focussed on the development and commercialisation of cellfree synthesis
1 min |
BioSpectrum Asia Feb 2023
BioSpectrum Asia
China's ReLive Biotechnologies strengthens presence in regenerative therapy market
Simultaneously with the acquisition, ReLive also completed its Series A financing of $36 million to fund the company’s global ambition.
1 min |
BioSpectrum Asia Feb 2023
BioSpectrum Asia
Seno Medical enters exclusive distributor agreement with Genetik
Seno Medical, based in the US, has entered into an exclusive distributor agreement with Genetik, to market, sell and service the company’s groundbreaking Imagio Opto-Acoustic/ Ultrasound (OA/US) Breast Imaging System.
1 min |
BioSpectrum Asia Feb 2023
BioSpectrum Asia
Malaysian Genomics explores R&D collaboration with SIRIM
Under the strategic cooperation, both parties will evaluate the potential commercial value of a range of genomicsdriven biotechnology R&D projects.
1 min |
BioSpectrum Asia Feb 2023
BioSpectrum Asia
Terumo and Siemens Healthineers collaborate to strengthen cardiac care in India
The collaboration will flag off its efforts with a customised training programme for Cathlab professionals, being developed in partnership with an eminent academic institute in India.
1 min |
BioSpectrum Asia Feb 2023
BioSpectrum Asia
Aculys Pharma, Four H initiate collaboration using wearable devices to study sleep disorders in Japan
In its quest to establish a new pharmaceutical model, Aculys is promoting DX (digital transformation) in clinical trials and medicine.
1 min |
BioSpectrum Asia Feb 2023
BioSpectrum Asia
Lotte Biologics announces $3 B investment plan to leap forward as global CDMO
Lotte Biologics CEO Richard Wonjik Lee has announced a blueprint to leap forward as a global contract development and manufacturing organisation (CDMO).
1 min |
BioSpectrum Asia Feb 2023
BioSpectrum Asia
Sun Pharma buys US-based Concert Pharma for $576 M
Sun Pharma’s immediate focus would be to follow Concert’s plan to submit a New Drug Application (NDA) to the US Food and Drug Administration (FDA) in the first half of 2023.
1 min |
BioSpectrum Asia Feb 2023
BioSpectrum Asia
SK bioscience's shingles vaccine receives biologics license application approval in Malaysia
SKYZoster is shown clinically acceptable immunogenicity and safety at Phase III clinical trial.
1 min |
BioSpectrum Asia Feb 2023
BioSpectrum Asia
Mobile app to help adolescents access public health services in Bangladesh
Millions of adolescents and youth in Bangladesh will be able to access health information and services through two online portals launched recently at The National Adolescent Health Conference held in Dhaka.
1 min |
BioSpectrum Asia Feb 2023
BioSpectrum Asia
New Zealand approves new therapy to treat rare gastrointestinal stromal tumour
Specialised Therapeutics Asia (ST), based in Singapore, has announced that a new therapy to treat rare gastrointestinal stromal tumour (GIST) shown to improve survival has now been approved in New Zealand.
1 min |
BioSpectrum Asia Feb 2023
BioSpectrum Asia
Indonesia's TB response gets $300 M programme World Bank loan
The World Bank’s Board of Executive Directors has approved a $300 million loan to the Indonesian government to improve coverage, quality and efficiency of tuberculosis (TB) response in Indonesia.
1 min |
BioSpectrum Asia Feb 2023
BioSpectrum Asia
Too Much Of A Good Thing...
Thinking long term to ensure that huge amounts of vaccines are not wasted, manufacturers need to have a far-sightedness and not just go on a production spree.
6 min |
January 2023
BioSpectrum Asia
Life Sciences Trends To Watch For In 2023
The past two years have been a rollercoaster ride for the global economy and the pharma industry hasn't been impervious to the major financial upheavals either.
10+ min |
January 2023
BioSpectrum Asia
HTAs, CGT Set to Rule Life Sciences Industry in 2023
overnments and other payers make decisions ee the context of the broader economic environment. For 2023 we will continue to see the impact of these global economic trends on payer decisions as they increase financial pressure in the APAC region.
4 min |
January 2023
BioSpectrum Asia
XtalPi joins hands with Singapore’s EDDC
For cancer drug discovery
1 min |
January 2023
BioSpectrum Asia
IVI, ST Pharm exchange MoU,
clinical development of COVID-19 vaccine
1 min |
January 2023
BioSpectrum Asia
Pharmaniaga strives to develop children’s hexavalent vaccine by 2023
Pharmaniaga LifeScience Sdn Bhd PLS), a wholly-owned subsidiary of Malaysia’s leading pharmaceutical company
1 min |
January 2023
BioSpectrum Asia
Alliance Pharma unveils state-of-the-art
bioanalytical lab in Brisbane
1 min |
January 2023
BioSpectrum Asia
Vaxxas raises A$34M to clinicall advance needle-free vaccines
Vaxxas has completed a financing round which raised 23 million A$34 million) in new funds.
1 min |
January 2023
BioSpectrum Asia
Merck, Kelun-Biotech ink $9.3B licensing pact for 7 cancer candidates in China
news about finance
1 min |
January 2023
BioSpectrum Asia
Prejex joins hands with Polybond to make needle-less injections in India
Prejex Inc., a spin-off of Germany-based Prejex GMBH, has entered into an agreement with Polybond, headed by Adit Rathi of Rathi Group to manufacture needleless injections.
1 min |
January 2023
BioSpectrum Asia
Thailand develops
speech recognition AI tech for screening depression
1 min |
January 2023
BioSpectrum Asia
Australian first research
trial to explore use of psychedelics for alcohol use disorder
1 min |
January 2023
BioSpectrum Asia
AstraZeneca India
appoints Dr Sanjeev Panchal as Country President MD
1 min |